What is Valtoco used for?
The U.S. Food and Drug Administration (FDA) has approved Valtoco® (diazepam nasal spray). This is a new seizure medicine designed to treat periods of frequent seizures or cluster seizures that are distinct from the person’s usual seizure pattern.
Is Nayzilam FDA approved?
The U.S. Food and Drug Administration approved the use of NAYZILAM® (midazolam) nasal spray CIV this week for use in children age 12 and over and adults with epilepsy. Nayzilam is a rescue therapy for acute (immediate, short-term) treatment of intermittent, stereotypic episodes of frequent seizure activity.
How do I get Valtoco?
Valtoco is now available through Maxor Specialty Pharmacy. Prescribing health care providers can send prescriptions to Maxor. This pharmacy will then contact the person with epilepsy to confirm insurance and other information, before delivering Valtoco to them.
Is Valtoco a controlled substance?
VALTOCO is a prescription medicine used for the short-term treatment of seizure clusters (also known as “episodes of frequent seizure activity” or “acute repetitive seizures”) in patients 6 years of age and older. VALTOCO is a federally controlled substance (CIV) because it can be abused or lead to dependence.
How long does it take Valtoco to work?
Valtoco reaches a peak level in the blood in about 1.5 hours and can last almost 2 days.
Is Valtoco a benzodiazepine?
VALTOCO® (diazepam nasal spray) is a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (ie, seizure clusters, acute repetitive seizures) that are distinct from a patient’s usual seizure pattern.
Is Nayzilam a benzo?
NAYZILAM is a benzodiazepine medicine. Taking benzodiazepines with opioid medicines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, breathing problems (respiratory depression), coma, and death.
How quickly does Nayzilam work?
How long does it take to work? For some people, one dose (5 milligrams) of Nayzilam is enough to stop a seizure cluster episode within 10 minutes. For others, a second dose is needed, if their doctor advises it.
What is the shelf life of Valtoco?
“We are excited that the FDA has extended the VALTOCO product expiration to more than two years,” said Craig Chambliss, the company’s President and Chief Executive Officer.
What is the name of the nasal spray for seizures?
NAYZILAM® (midazolam) nasal spray, CIV is a prescription medicine used for the short-term treatment of seizure clusters (also known as acute repetitive seizures) in patients 12 years of age and older. Eva W. is an actual patient living with seizure clusters.
Should Valtoco be primed?
Give VALTOCO 15 mg dose or 20 mg dose. 1 dose equals 2 nasal spray devices. Each device sprays one time only. Important: Do not test or prime VALTOCO.
Are there any side effects to taking valtoco?
There is a risk for abuse, misuse, and addiction with benzodiazepines, including VALTOCO, which can lead to overdose and serious side effects including coma and death. Serious side effects have happened in people who have abused or misused benzodiazepines, including diazepam (the active ingredient in VALTOCO).
Why is valtoco considered a federally controlled substance?
VALTOCO is a federally controlled substance (CIV) because it can be abused or lead to dependence. Keep VALTOCO in a safe place to prevent misuse and abuse. Selling or giving away VALTOCO may harm others and is against the law. Tell your healthcare provider if you have abused or been dependent on alcohol, prescription drugs, or street drugs.
How old do you have to be to take valtoco?
What is VALTOCO ® (diazepam nasal spray)? VALTOCO is a prescription medicine used for the short-term treatment of seizure clusters (also known as “episodes of frequent seizure activity” or “acute repetitive seizures”) in patients 6 years of age and older.
What should I know before taking valtoco nasal spray?
Before using VALTOCO, tell your healthcare provider about all of your medical conditions, including if you: Have asthma, emphysema, bronchitis, chronic obstructive pulmonary disease, or other breathing problems. Have a history of alcohol or drug abuse. Have a history of depression, mood problems, or suicidal thoughts or behavior.